Kim CJ, Kim NH, Song KH, Choe PG, Kim ES, Park SW, et al. Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media. Diagn Microbiol Infect Dis. 2013;75(1):73–6.
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185–226.
Article CAS PubMed PubMed Central Google Scholar
Chan CH, Ho AK, Chan RC, Cheung H, Cheng AF. Mycobacteria as a cause of infective exacerbation in bronchiectasis. Postgrad Med J. 1992;68(805):896–9.
Article CAS PubMed PubMed Central Google Scholar
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. Lady Windermere Syndrome Chest. 1992;101(6):1605–9.
Zhou Y, Mu W, Zhang J, Wen SW, Pakhale S. Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis. BMJ Open. 2022;12(8): e055672.
Article PubMed PubMed Central Google Scholar
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1-64.
Braeckel EV, Bosteels C. Growing from common ground: nontuberculous mycobacteria and bronchiectasis. Eur Respiratory Rev. 2024;33(173)
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.
Article CAS PubMed Google Scholar
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, et al. Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study. Thorax. 2023;78(8):825–34.
Chalmers JD, Aksamit T, Carvalho ACC, Rendon A, Franco I. Non-tuberculous mycobacterial pulmonary infections. Pulmonology. 2018;24(2):120–31.
Griffith DE, Aksamit TR. Understanding nontuberculous mycobacterial lung disease: it’s been a long time coming. F1000Res. 2016;5:2797.
Article PubMed PubMed Central Google Scholar
Lake MA, Ambrose LR, Lipman MCI, Lowe DM. ‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14(1):54.
Article PubMed PubMed Central Google Scholar
Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy - Volume 15, Number 10—October 2009 - Emerging Infectious Diseases journal - CDC
Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–62.
Markle JG, Martĺnez-Barricarte R, Ma CS, Deenick EK, Ramírez-Alejo N, Mele F, et al. Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3(30):eaau6759.
Article PubMed PubMed Central Google Scholar
DeFlorio-Barker S, Egorov A, Smith GS, Murphy MS, Stout JE, Ghio AJ, et al. Environmental risk factors associated with pulmonary isolation of nontuberculous mycobacteria, a population-based study in the southeastern United States. Sci Total Environ. 2021;1(763):144552.
Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178(10):1066–74.
Article CAS PubMed PubMed Central Google Scholar
Loebinger MR, Quint JK, van der Laan R, Obradovic M, Chawla R, Kishore A, et al. Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis. Chest. 2023;164(5):1115–24.
Grasemann H, Ratjen F. Cystic Fibrosis. N Engl J Med. 2023;389(18):1693–707.
Article CAS PubMed Google Scholar
Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, et al. Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. Am J Respir Crit Care Med. 2015;192(5):618–28.
Article CAS PubMed PubMed Central Google Scholar
Chen S, Zhong J, Yang Q, Song X, Zhang L, Ruan G, et al. Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study. BMC Infect Dis. 2024;24(1):1159.
Article CAS PubMed PubMed Central Google Scholar
Wobma H, Chang AK, Jin Z, Baker C, Garvin J, George D, et al. Low CD4 count may be a risk factor for non-tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients. Pediatr Transplant. 2021;25(4): e13994.
Article CAS PubMed Google Scholar
Garcia B, Wilmskoetter J, Grady A, Mingora C, Dorman S, Flume P. Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study. J Thorac Imaging. 2022;37(3):140.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Eur Respir J. 2020;56(1):2000535.
Article PubMed PubMed Central Google Scholar
Lee MR, Yang CY, Shu CC, Lin CK, Wen YF, Lee SW, et al. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination. Clin Microbiol Infect. 2015;21(3):250.e1-7.
van Ingen J, Bendien SA, de Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region. The Netherlands Thorax. 2009;64(6):502–6.
Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013;10(4):299–306.
Kuroishi S, Nakamura Y, Hayakawa H, Shirai M, Nakano Y, Yasuda K, et al. Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings. Eur Respir J. 2008;32(1):147–52.
Article CAS PubMed Google Scholar
Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;173(11):1283–9.
Article CAS PubMed Google Scholar
Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY, Yu CJ, et al. Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns. Lung. 2011;189(6):467–74.
Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol. 2016;54(2):120–7.
Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185(5):575–83.
Article CAS PubMed Google Scholar
Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax. 2008;63(7):627–34.
Comments (0)